A Phase 3, Randomised, Observer-blind, Placebo-controlled, Multi-centre Study to Evaluate the Immune Response and Safety of the Herpes Zoster Subunit Vaccine When Administered Intramuscularly on a 2-dose Schedule in Adults Aged 50 Years and Older in India

Name: A Phase 3, Randomised, Observer-blind, Placebo-controlled, Multi-centre Study to Evaluate the Immune Response and Safety of the Herpes Zoster Subunit Vaccine When Administered Intramuscularly on a 2-dose Schedule in Adults Aged 50 Years and Older in India
Creator: Vivli
Published: 2025-06-25 14:16:52
License: 暂无描述

DataCite Commons2025-06-25 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00011221/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

The purpose of this study was to evaluate the humoral immunogenicity and safety of 2 doses of GSK Biologicals' Herpes Zoster subunit vaccine (HZ/su) administered for the prevention of Herpes Zoster (HZ) in adults aged 50 years of age (YOA) or older from India.

提供机构：

Vivli

创建时间：

2025-03-21